BNP PARIBAS FINANCIAL MARKETS - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 148 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2020. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$423,808
+111.9%
77,763
+160.9%
0.00%
Q2 2023$200,005
-65.4%
29,807
-54.5%
0.00%
-100.0%
Q1 2023$578,383
+91.4%
65,502
+65.6%
0.00%
Q4 2022$302,154
-99.9%
39,549
-53.0%
0.00%
-100.0%
Q3 2022$598,529,000
+94.9%
84,063
+121.4%
0.00%
Q2 2022$307,161,000
+160.8%
37,968
+347.5%
0.00%
Q1 2022$117,772,000
+34.3%
8,485
+171.4%
0.00%
Q4 2021$87,716,000
-17.4%
3,126
+0.1%
0.00%
Q3 2021$106,151,000
+55.0%
3,123
+86.3%
0.00%
Q2 2021$68,481,000
-48.9%
1,676
-49.7%
0.00%
Q1 2021$134,106,000
-17.1%
3,331
+21.7%
0.00%
Q4 2020$161,839,000
+182.0%
2,737
+131.9%
0.00%
Q3 2020$57,383,000
-59.8%
1,180
-60.1%
0.00%
Q2 2020$142,915,000
+218.7%
2,954
+83.0%
0.00%
Q1 2020$44,837,000
+89.9%
1,614
+104.6%
0.00%
Q4 2019$23,607,000
+14.0%
789
+17.8%
0.00%
Q3 2019$20,703,0006700.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q1 2020
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$20,334,21213.72%
BERYLSON CAPITAL PARTNERS, LLC 228,000$1,529,8804.32%
Eagle Health Investments LP 1,214,860$8,151,7111.52%
Matrix Capital Management Company, LP 11,572,590$77,652,0790.90%
Triatomic Management LP 121,166$813,0240.83%
VIKING GLOBAL INVESTORS LP 29,993,708$201,257,7810.82%
Aristotle Atlantic Partners, LLC 3,104,961$20,834,2880.78%
Pier Capital, LLC 737,589$4,949,2220.71%
ARK Investment Management 10,453,752$70,144,6750.46%
Nikko Asset Management Americas, Inc. 6,384,047$42,773,1150.45%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders